60.22
price up icon0.89%   0.53
after-market After Hours: 60.22
loading
Corcept Therapeutics Inc stock is traded at $60.22, with a volume of 536.01K. It is up +0.89% in the last 24 hours and up +29.31% over the past month. Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
See More
Previous Close:
$59.69
Open:
$60
24h Volume:
536.01K
Relative Volume:
0.32
Market Cap:
$6.46B
Revenue:
$769.10M
Net Income/Loss:
$46.67M
P/E Ratio:
172.06
EPS:
0.35
Net Cash Flow:
$119.79M
1W Performance:
+6.83%
1M Performance:
+29.31%
6M Performance:
-22.09%
1Y Performance:
-20.86%
1-Day Range:
Value
$59.54
$60.95
1-Week Range:
Value
$54.59
$60.95
52-Week Range:
Value
$28.66
$91.00

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name
Name
Corcept Therapeutics Inc
Name
Phone
650.688.8803
Name
Address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
Employee
730
Name
Twitter
Name
Next Earnings Date
2026-04-30
Name
Latest SEC Filings
Name
CORT's Discussions on Twitter

Compare CORT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CORT icon
CORT
Corcept Therapeutics Inc
60.22 6.41B 769.10M 46.67M 119.79M 0.35
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
434.52 110.03B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
638.88 67.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
806.46 50.76B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
297.45 40.12B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
151.56 32.68B 742.00K -1.37B -1.07B -7.0731

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-26-26 Upgrade Wolfe Research Underperform → Peer Perform
Dec-31-25 Downgrade Wolfe Research Peer Perform → Underperform
Dec-16-25 Initiated UBS Neutral
Nov-18-25 Initiated Wolfe Research Peer Perform
Nov-06-23 Upgrade Truist Hold → Buy
Apr-11-23 Initiated SVB Securities Market Perform
Apr-04-23 Initiated Piper Sandler Overweight
Feb-15-23 Downgrade Jefferies Buy → Hold
Aug-01-22 Downgrade Truist Buy → Hold
Jul-27-22 Upgrade Jefferies Hold → Buy
Jun-27-22 Resumed Canaccord Genuity Buy
Feb-02-22 Initiated Canaccord Genuity Buy
Jan-28-22 Initiated Truist Buy
Aug-05-20 Downgrade Jefferies Buy → Hold
Sep-24-19 Initiated Jefferies Buy
Sep-06-19 Initiated H.C. Wainwright Buy
Feb-04-19 Downgrade B. Riley FBR Buy → Neutral
Aug-10-18 Reiterated Stifel Hold
May-31-18 Downgrade Stifel Buy → Hold
Mar-09-18 Initiated B. Riley FBR, Inc. Buy
Aug-31-17 Initiated Stifel Buy
Feb-02-17 Initiated Ladenburg Thalmann Buy
Apr-21-15 Initiated FBR Capital Outperform
Jan-13-14 Downgrade Stifel Buy → Hold
Aug-09-13 Downgrade Janney Buy → Neutral
Aug-09-13 Downgrade Ladenburg Thalmann Buy → Neutral
Feb-21-12 Reiterated JMP Securities Mkt Outperform
Jan-06-10 Upgrade Ladenburg Thalmann Neutral → Buy
Jul-17-08 Initiated Rodman & Renshaw Mkt Outperform
Jun-21-07 Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
View All

Corcept Therapeutics Inc Stock (CORT) Latest News

pulisher
May 22, 2026

CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill

May 22, 2026
pulisher
May 20, 2026

Affiliate of CORT (NASDAQ: CORT) files Form 144 to offer 5,000 shares - Stock Titan

May 20, 2026
pulisher
May 19, 2026

Wall Street Analysts Believe Corcept (CORT) Could Rally 43.32%: Here's is How to Trade - Yahoo Finance UK

May 19, 2026
pulisher
May 18, 2026

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors - DirectorsTalk Interviews

May 18, 2026
pulisher
May 15, 2026

Corcept (CORT) chief business officer reports 7,300-share gift of common stock - Stock Titan

May 15, 2026
pulisher
May 14, 2026

CORT Stock Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill

May 14, 2026
pulisher
May 13, 2026

UBS upgrades Corcept Therapeutics (CORT) - MSN

May 13, 2026
pulisher
May 13, 2026

Corcept Therapeutics (CORT) Receives Upgrade, Stock Surges Over 7% - GuruFocus

May 13, 2026
pulisher
May 13, 2026

Corcept Therapeutics Shares Rise After UBS Upgrade - Moomoo

May 13, 2026
pulisher
May 13, 2026

UBS Upgrades Corcept Therapeutics(CORT.US) to Buy Rating, Cuts Target Price to $72 - Moomoo

May 13, 2026
pulisher
May 13, 2026

Corcept Therapeutics climbs on UBS upgrade - MSN

May 13, 2026
pulisher
May 11, 2026

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

May 11, 2026
pulisher
May 08, 2026

CORT Q1 earnings match estimates, revenues miss, 2026 outlook raised - MSN

May 08, 2026
pulisher
May 08, 2026

Vanguard Group Inc. Has $330.42 Million Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat

May 08, 2026
pulisher
May 07, 2026

Why Corcept Therapeutics Stock Is Sinking Now - TipRanks

May 07, 2026
pulisher
May 07, 2026

CORT IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 07, 2026
pulisher
May 07, 2026

Corcept (CORT) CDO sells 20K shares under 10b5-1 plan - Stock Titan

May 07, 2026
pulisher
May 07, 2026

CORT FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 07, 2026
pulisher
May 07, 2026

Corcept Therapeutics (CORT) Is Up 11.9% After Q1 Loss, Higher 2026 Outlook And ALS DataHas The Bull Case Changed? - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Corcept (CORT) Q1 2025 Earnings Transcript - AOL.com

May 07, 2026
pulisher
May 06, 2026

Corcept Must Face Most Teva Mifepristone Antitrust Claims - Law360

May 06, 2026
pulisher
May 06, 2026

Corcept Therapeutics IncorporatedCommon Stock (NQ: CORT - FinancialContent

May 06, 2026
pulisher
May 06, 2026

How many employees work at Corcept Therapeutics? - Revelio Labs

May 06, 2026
pulisher
May 05, 2026

Teva's US exclusive-dealing claims survive Corcept's move to dismiss - MLex

May 05, 2026
pulisher
May 05, 2026

Corcept (NASDAQ: CORT) CEO sells 40K shares under 10b5-1 plan - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Corcept Therapeutics (NASDAQ: CORT) affiliate plans sale of 20,000 shares via Stifel - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript - Insider Monkey

May 05, 2026
pulisher
May 05, 2026

CORT Q1 Deep Dive: Early Lifyorli Launch and Endocrinology Momentum Offset Margin Pressures - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Corcept (CORT) Q1 2026 Earnings Transcript - AOL.com

May 05, 2026
pulisher
May 04, 2026

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co. - Moomoo

May 04, 2026
pulisher
May 04, 2026

CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $110 - Moomoo

May 04, 2026
pulisher
May 04, 2026

Corcept (CORT) Q2 2025 Earnings Transcript - AOL.com

May 04, 2026
pulisher
May 04, 2026

Corcept (CORT) Q4 2025 Earnings Transcript - AOL.com

May 04, 2026
pulisher
May 04, 2026

CORT Maintained by HC Wainwright & Co. -- Price Target Raised to $75 - GuruFocus

May 04, 2026
pulisher
May 04, 2026

CORT DEADLINE: ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 04, 2026
pulisher
May 04, 2026

Corcept Therapeutics Inc. (CORT) Stock Analysis: A 36.91% Upside Potential In Biotech - DirectorsTalk Interviews

May 04, 2026
pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026
pulisher
May 02, 2026

Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli - Yahoo Finance

May 02, 2026
pulisher
May 01, 2026

Corcept Therapeutics Shakes Up Nasdaq Index Fund Radar - Kalkine Media

May 01, 2026
pulisher
May 01, 2026

CORT Maintained by Piper Sandler -- Price Target Raised to $88 - GuruFocus

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics Guides Higher on Lifyorli-Fueled Revenue Growth - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler - Moomoo

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 7.9%Time to Buy? - MarketBeat

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics (CORT) insider notifies sale of 40,000 shares via Stifel - Stock Titan

May 01, 2026
pulisher
May 01, 2026

CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics Pivotal Study Shows 87% Lower Death Risk - Benzinga

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics Incorporated Q1 2026 Earnings Call Summary - Yahoo Finance

May 01, 2026
pulisher
May 01, 2026

Corcept Therapeutics Inc (CORT) Q1 2026 Earnings Call Highlights - GuruFocus

May 01, 2026

Corcept Therapeutics Inc Stock (CORT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$29.96
price down icon 2.98%
$106.24
price down icon 3.00%
$92.14
price up icon 1.33%
$54.50
price up icon 1.77%
ONC ONC
$310.25
price up icon 0.20%
$151.56
price down icon 1.41%
Cap:     |  Volume (24h):